John Melissas1, Konstantinos Stavroulakis2, Vassilis Tzikoulis2, Angeliki Peristeri2, John A Papadakis3, Abdolreza Pazouki4, Alireza Khalaj5, Ali Kabir4. 1. Bariatric Unit, Heraklion University Hospital, 164 Erythreas str, 71409, Heraklion, Greece. melissas@uoc.gr. 2. Bariatric Unit, Heraklion University Hospital, 164 Erythreas str, 71409, Heraklion, Greece. 3. Department of Internal Medicine, Heraklion University Hospital, Heraklion, Crete, Greece. 4. Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran. 5. Tehran Obesity Treatment Center, Department of Surgery, Shahed University, Tehran, Iran.
Abstract
BACKGROUND: The purpose of this study is to compare sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGBP) performed in Institutions participating in IFSO-European Chapter, Center of Excellence (COE) program. METHODS: Since the initiation of the program in January 2010, 6413 SGs and 10,622 RYGBPs performed as primary procedures by December 31, 2014, with at least 12-month follow-up, were retrospectively compared. RESULTS: There were steadily increasing numbers of patients underwent SG from 2010 to 2015. Early (<30 days) postoperative complication rate of 3.02 % for RYGBP was significantly higher than 2.12 % seen after SG (p = 0.0006). Only two patients, one in each group, died in the first 30 postoperative days (0.016 % mortality for SG vs 0.009 % for RYGBP-NS). From SG group, 103 patients, 1.61 %, and 206 patients, 1.94 %, from RYGBP group required readmission following hospital discharge in the first 30 days following bariatric surgery-NS. From the readmitted patients in the SG group, 75.72 % were reoperated vs 50.50 % in the RYGBP group (p < 0.0001). SG patients were heavier (BMI 44.93 vs 43.96 kg/m2, p < 0.0001). However, significantly better % excess weight loss were seen following RYGBP in all postoperative years (60.36 vs 67.72 %, p = 0.002 at fifth year). Better remission rates were seen for diabetes, arterial hypertension, dyslipidemia, and sleep apnea syndrome after RYGBP in the first postoperative year. CONCLUSIONS: Both procedures were performed with very low complications, mortality, readmissions, and reoperations rate. Better weight loss was observed following RYGBP, the first five postoperative years.
BACKGROUND: The purpose of this study is to compare sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGBP) performed in Institutions participating in IFSO-European Chapter, Center of Excellence (COE) program. METHODS: Since the initiation of the program in January 2010, 6413 SGs and 10,622 RYGBPs performed as primary procedures by December 31, 2014, with at least 12-month follow-up, were retrospectively compared. RESULTS: There were steadily increasing numbers of patients underwent SG from 2010 to 2015. Early (<30 days) postoperative complication rate of 3.02 % for RYGBP was significantly higher than 2.12 % seen after SG (p = 0.0006). Only two patients, one in each group, died in the first 30 postoperative days (0.016 % mortality for SG vs 0.009 % for RYGBP-NS). From SG group, 103 patients, 1.61 %, and 206 patients, 1.94 %, from RYGBP group required readmission following hospital discharge in the first 30 days following bariatric surgery-NS. From the readmitted patients in the SG group, 75.72 % were reoperated vs 50.50 % in the RYGBP group (p < 0.0001). SG patients were heavier (BMI 44.93 vs 43.96 kg/m2, p < 0.0001). However, significantly better % excess weight loss were seen following RYGBP in all postoperative years (60.36 vs 67.72 %, p = 0.002 at fifth year). Better remission rates were seen for diabetes, arterial hypertension, dyslipidemia, and sleep apnea syndrome after RYGBP in the first postoperative year. CONCLUSIONS: Both procedures were performed with very low complications, mortality, readmissions, and reoperations rate. Better weight loss was observed following RYGBP, the first five postoperative years.
Entities:
Keywords:
Bariatric surgery; Center of Excellence; John Melissas and Konstantinos Stavroulakis contributed equally in this article.; Morbid obesity; Roux-en-Y gastric bypass; Sleeve gastrectomy
Authors: John K Saunders; Garth H Ballantyne; Scott Belsley; Daniel Stephens; Amit Trivedi; Douglas R Ewing; Vincent Iannace; Rafael F Capella; Annette Wasielewski; S Moran; Hans J Schmidt Journal: Obes Surg Date: 2007-09 Impact factor: 4.129
Authors: Arezou Yaghoubian; Amy Tolan; Bruce E Stabile; Amy H Kaji; Gary Belzberg; Edward Mun; Robert Zane Journal: Am Surg Date: 2012-12 Impact factor: 0.688
Authors: Jaime Ruiz-Tovar; Miguel Angel Carbajo; Jose Maria Jimenez; Maria Jose Castro; Gilberto Gonzalez; Javier Ortiz-de-Solorzano; Lorea Zubiaga Journal: Surg Endosc Date: 2018-06-25 Impact factor: 4.584
Authors: Mario Masrur; Roberto Bustos; Lisa Sanchez-Johnsen; Luis Gonzalez-Ciccarelli; Alberto Mangano; Raquel Gonzalez-Heredia; Ronak Patel; Kirstie K Danielson; Antonio Gangemi; Enrique Fernando Elli Journal: Obes Surg Date: 2020-03 Impact factor: 4.129
Authors: Miguel A Carbajo; Gilberto Gonzalez-Ramirez; Jose Maria Jimenez; Enrique Luque-de-Leon; Javier Ortiz-de-Solorzano; Maria Jose Castro; Jaime Ruiz-Tovar Journal: Obes Surg Date: 2019-09 Impact factor: 4.129